GlaxoSmithKline (NYSE: GSK) has extended its $2.6 billion takeover offer for Human Genome Sciences (NASDAQ: HGSI) until the end of this month. The original tender period expired on June 7. GKS has now extended the tender period to June 29.
[...]
|
||
GlaxoSmithKline (NYSE: GSK) has extended its $2.6 billion takeover offer for Human Genome Sciences (NASDAQ: HGSI) until the end of this month. The original tender period expired on June 7. GKS has now extended the tender period to June 29. [...] |
||
Copyright © 2024 Daily Stocks News - All Rights Reserved Powered by WordPress & Atahualpa |
Recent Comments